Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Romaguera

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1990
Responsiveness of L-S ratio of the amniotic fluid to intra-amniotic administration of thyroxine. Role of fetal ageJ Romaguera, C Zorrilla, A de la Vega, et al.
Blood|March 26, 1999
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic featuresJ Rodriguez, P McLaughlin, F B Hagemeister, et al.
American Journal of Clinical Pathology|December 10, 1999
De novo CD5+ Burkitt lymphoma/leukemiaC W Lin, S O'Brien, J Faber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up studyW S Velasquez, P McLaughlin, S Tucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981J Rodriguez, P McLaughlin, L Fayad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvementC Visco, L J Medeiros, D Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphomaA Younes, A Sarris, A Melnyk, et al.
Blood|May 26, 1999
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's diseaseJ Rodriguez, M A Rodriguez, L Fayad, et al.
Journal of Racial and Ethnic Health Disparities|June 9, 2016
Factors Associated with HPV Vaccine Awareness in a Population-Based Sample of Hispanic Women in Puerto RicoJ Romaguera, D Caballero-Varona, G Tortolero-Luna, et al.
Leukemia|September 28, 2007
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivoM Wang, X H Han, L Zhang, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1990
Responsiveness of L-S ratio of the amniotic fluid to intra-amniotic administration of thyroxine. Role of fetal ageJ Romaguera, C Zorrilla, A de la Vega, et al.
Blood|March 26, 1999
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic featuresJ Rodriguez, P McLaughlin, F B Hagemeister, et al.
American Journal of Clinical Pathology|December 10, 1999
De novo CD5+ Burkitt lymphoma/leukemiaC W Lin, S O'Brien, J Faber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up studyW S Velasquez, P McLaughlin, S Tucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981J Rodriguez, P McLaughlin, L Fayad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvementC Visco, L J Medeiros, D Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphomaA Younes, A Sarris, A Melnyk, et al.
Blood|May 26, 1999
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's diseaseJ Rodriguez, M A Rodriguez, L Fayad, et al.
Journal of Racial and Ethnic Health Disparities|June 9, 2016
Factors Associated with HPV Vaccine Awareness in a Population-Based Sample of Hispanic Women in Puerto RicoJ Romaguera, D Caballero-Varona, G Tortolero-Luna, et al.
Leukemia|September 28, 2007
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivoM Wang, X H Han, L Zhang, et al.
Pageof 6